This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strålin, K.
Right arrow Articles by Holmberg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strålin, K.
Right arrow Articles by Holmberg, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2006, p. 643-645, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.643-645.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Etiologic Diagnosis of Adult Bacterial Pneumonia by Culture and PCR Applied to Respiratory Tract Samples

Kristoffer Strålin,1* Eva Törnqvist,2 Margit Staum Kaltoft,3 Per Olcén,2 and Hans Holmberg1

Departments of Infectious Diseases,1 Clinical Microbiology, Örebro University Hospital, Örebro, Sweden,2 Streptococcus Unit, Division of Microbiology and Diagnostics, Statens Serum Institut, Copenhagen, Denmark3

Received 8 September 2005/ Accepted 8 November 2005


arrow
ABSTRACT
 
Respiratory culture and multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, and Chlamydophila pneumoniae were applied to sputum, nasopharyngeal swabs, and nasopharyngeal aspirates from 235 adult patients with community-acquired pneumonia and 113 controls. Both culture and multiplex PCR performed well with the different samples and appear to be useful as diagnostic tools.


arrow
TEXT
 
As an etiologic agent can rarely be identified in more than 50% of patients with community-acquired pneumonia (CAP) (9), further development of diagnostic methods has been encouraged (4, 10).

The aim of the present study was to estimate the diagnostic accuracy of respiratory culture and a single-run multiplex PCR (mPCR) for specific genes of Streptococcus pneumoniae (lytA), Haemophilus influenzae (16S rRNA, with verification by PCR for P6), Mycoplasma pneumoniae (P1), and Chlamydophila pneumoniae (ompA) (12) applied to respiratory samples in CAP patients.

(The study was approved by the ethics committee of the Örebro County Council [868-1999; 556-2000].)

In a prospective study described previously (14), 235 hospitalized CAP patients with X-ray infiltrates were enrolled. Their median age was 71 years (age range, 18 to 96 years), 40% belonged to severity risk classes IV and V, 14% had chronic obstructive pulmonary disease, and 22% were smokers. In 82% of the patients, the interval from the onset of illness to admission was 0 to 7 days.

During the study period, 113 adult controls (median age, 69 years) without respiratory symptoms were enrolled. They were hospitalized for skin infection (n = 14), urinary tract infection (n = 14), arthritis or spondylitis (n = 6), or planned orthopedic or urological surgery (n = 79).

The results of the respiratory cultures and mPCR analyses performed with specimens from the patients and the controls are shown in Table 1. Sputum samples were analyzed if there were more than five leukocytes per squamous epithelial cell (6). To obtain a nasopharyngeal aspirate (NpA), secretions from the nasopharynx were aspirated by a catheter connected to an electronic suction device. About 1 ml NaCl (0.85%) was then aspirated to collect the secretions situated within the catheter. Culture and mPCR of sputum, nasopharyngeal swabs (NpSs), and NpAs were performed as described previously (12). Multiplex PCR was performed blindly with samples previously frozen at –70°C.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Analyses of respiratory tract secretions for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, and Chlamydophila pneumoniae in 235 patients with CAP and 113 controls

To establish the definite etiologies of CAP, we performed the following: blood culture for 235 patients, the NOW S. pneumoniae urinary antigen test (Binax) for 215 patients, the complement fixation test for M. pneumoniae (8) with paired serum specimens for 216 patients, the microimmunofluorescence test for C. pneumoniae (3) with paired serum specimens for 216 patients, and the indirect immunofluorescence test for H. influenzae (13) with paired serum specimens for 48 patients.

Our criteria for definite CAP etiologies were as follows: for S. pneumoniae, a positive blood culture or a positive urinary antigen test (only visible result lines at least as intense as the control line were considered positive; other results were considered negative) (14); for H. influenzae, a positive blood culture or a positive indirect immunofluorescence test, i.e., a fourfold or greater rise in the immunoglobulin G (IgG) antibody titer against the patient's own H. influenzae isolate (13); for M. pneumoniae, a positive complement fixation test result, i.e., a fourfold or greater rise in the antibody titer; and for C. pneumoniae, a positive microimmunofluorescence test result, i.e., a fourfold or greater rise in the IgG antibody titer or an IgM titer ≥1/16.

The pathogens for which tests were performed were established as the definite etiologic agents in 79 (34%) of the 235 CAP patients, i.e., S. pneumoniae in 39 patients (17%), H. influenzae in 23 patients (9.8%), M. pneumoniae in 13 patients (5.5%), C. pneumoniae in 2 patients (0.9%), both S. pneumoniae and H. influenzae in 1 patient (0.4%), and both H. influenzae and C. pneumoniae in 1 patient (0.4%).

Tables 2 and 3 show the sensitivities and the specificities of the respiratory cultures and mPCR analyses.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Performance of culture and mPCR for Streptococcus pneumoniae and Haemophilus influenzae for pneumonia patients without ongoing antibiotic treatment


View this table:
[in this window]
[in a new window]
  		TABLE 3. Performance of mPCR for Mycoplasma pneumoniae and Chlamydophila pneumoniae in pneumonia patients without ongoing treatment with fluoroquinolones, macrolides, or tetracyclines

In the specificity calculations, our criteria for the exclusion of pathogens as etiologic agents were as follows: for S. pneumoniae, a negative blood culture plus a negative urinary antigen test result; for M. pneumoniae, a negative complement fixation test result with paired serum specimens; and for C. pneumoniae, a negative microimmunofluorescence test result with paired serum specimens. No diagnostic method was available to rule out H. influenzae as the etiologic agent, as the indirect immunofluorescence test could be performed only for culture-positive patients. Thus, no specificity could be calculated. However, among the 54 CAP patients with definite etiologies other than H. influenzae, this pathogen was identified by the culture of sputum for 0% of the patients (0 of 28), NpSs for 3.8% of the patients (2 of 53), and NpAs for 4.3% of the patients (2 of 47) and by mPCR of sputum for 7.7% of the patients (2 of 26), NpSs for 4.3% of the patients (2 of 47), and NpAs for 8.5% of the patients (4 of 47). These results indicate that the tests for H. influenzae had high specificities.

The usefulness of respiratory culture and mPCR was further supported by the low frequencies of pathogens identified in the control group (Table 1).

Sputum remains the respiratory sample of choice for establishment of the etiology of CAP, as it is well studied for the identification of both typical (1) and atypical (2, 7, 11) bacteria. However, the present study indicates that when sputum is unobtainable, NpSs or NpAs could be used for diagnostic testing. NpAs appear to be more useful than NpSs for establishment of the etiology of CAP, as NpAs generally showed higher sensitivities and as NpAs and sputum samples performed similarly. Among 99 patients for whom both sputum samples and NpAs were analyzed, the two samples gave identical results for S. pneumoniae for 88% of the patients (n = 87) by culture and for 85% of the patients (n = 84) by mPCR, and the two samples gave identical results for H. influenzae for 92% of the patients (n = 91) by culture and for 86% of the patients (n = 85) by mPCR. However, NpSs displayed higher specificities than NpAs for S. pneumoniae, and NpS culture has previously been found to be specific for pneumococcal pneumonia (5). Thus, if a high specificity for S. pneumoniae is mainly sought, NpSs should reasonably be preferable to NpAs.

In patients not treated with antibiotics, culture and mPCR had similar yields for S. pneumoniae and H. influenzae (Table 2). Antibiotics were taken prior to the collection of one or more respiratory samples in 66 CAP patients. In total, 138 respiratory samples were collected during antibiotic treatment, and there was no difference between the results of culture and mPCR for the identification of H. influenzae, while S. pneumoniae was identified by culture in 4.3% of the patients (n = 6) and by mPCR in 14% of the patients (n = 20) (P = 0.004, chi-square test). During antibiotic treatment in a previous study (15), PCR for S. pneumoniae with sputum often remained positive, while sputum culture became negative. Another major advantage of mPCR compared with culture in antibiotic-treated patients is its ability to identify M. pneumoniae and C. pneumoniae, as an atypical etiology may be a reason for a nonresponse to first-line CAP treatment.

Since the four pathogens identified by mPCR are common etiologic agents of CAP (9) and since the sensitivities of mPCR were moderate to high, negative mPCR results may be used to rule out these etiologies. When mPCR is positive for a single pathogen, the negative results for the other three pathogens increase the likelihood that the positive result is truly positive.

Based on the present results, we suggest that respiratory culture and mPCR applied to sputum, NpSs, and NpAs can be used to obtain presumptive diagnoses of the etiology of CAP in adult populations with expectedly low rates of carriage of respiratory pathogens. These presumptive diagnoses can guide antibiotic therapy and support treatment with narrow-spectrum antibiotics.


arrow
ACKNOWLEDGMENTS
 
This study was supported by grants from the Research Committee of Örebro County Council and the Örebro University Hospital Research Foundation.

We thank Birgitta Ekström for skillful technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Infectious Diseases, Örebro University Hospital, SE-70185 Örebro, Sweden. Phone: 46196023619. Fax: 4619184855. E-mail: kristoffer.stralin{at}orebroll.se. Back


arrow
REFERENCES
 
    1
  1. Bartlett, J. G. 2004. Diagnostic test for etiologic agents of community-acquired pneumonia. Infect. Dis. Clin. N. Am. 18:809-827.[CrossRef][Medline]
    2. 2
  2. Dorigo-Zetsma, J. W., R. P. Verkooyen, H. P. van Helden, H. van der Nat, and J. M. van den Bosch. 2001. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J. Clin. Microbiol. 39:1184-1186.[Abstract/Free Full Text]
    3. 3
  3. Dowell, S. F., R. W. Peeling, J. Boman, G. M. Carlone, B. S. Fields, J. Guarner, M. R. Hammerschlag, L. A. Jackson, C. C. Kuo, M. Maass, T. O. Messmer, D. F. Talkington, M. L. Tondella, and S. R. Zaki. 2001. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33:492-503.[CrossRef][Medline]
    4. 4
  4. File, T. M. 2003. Community-acquired pneumonia. Lancet 362:1991-2001.[CrossRef][Medline]
    5. 5
  5. Hedlund, J., Å. Örtqvist, and M. Kalin. 1990. Nasopharyngeal culture in the pneumonia diagnosis. Infection 18:283-285.[CrossRef][Medline]
    6. 6
  6. Kalin, M., A. A. Lindberg, and G. Tunevall. 1983. Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Leukocytes or alveolar macrophages as indicators of sample representativity. Scand. J. Infect. Dis. 15:153-160.[Medline]
    7. 7
  7. Kuoppa, Y., J. Boman, L. Scott, U. Kumlin, I. Eriksson, and A. Allard. 2002. Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J. Clin. Microbiol. 40:2273-2274.[Abstract/Free Full Text]
    8. 8
  8. Lenette, D. A. 1995. General principles for laboratory diagnosis of viral, rickettsial, and chlamydial infections, p. 3-25. In E. H. Lenette, D. A. Lenette, and E. T. Lenette (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 7th ed. American Public Health Association, Washington, D.C.
    9. 9
  9. Marrie, T. J. 2001. Etiology of community-acquired pneumonia, p. 131-141. In T. J. Marrie (ed.), Community-acquired pneumonia. Kluwer Academic/Plenum Publishers, New York, N.Y.
    10. 10
  10. Marston, B. J., J. F. Plouffe, T. M. File, Jr., B. A. Hackman, S. J. Salstrom, H. B. Lipman, M. S. Kolczak, R. F. Breiman, et al. 1997. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. Arch. Intern. Med. 157:1709-1718.[Abstract/Free Full Text]
    11. 11
  11. Murdoch, D. R. 2003. Diagnosis of Legionella infection. Clin. Infect. Dis. 36:64-69.[CrossRef][Medline]
    12. 12
  12. Strålin, K., A. Bäckman, H. Holmberg, H. Fredlund, and P. Olcén. 2005. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS 113:99-111.[CrossRef][Medline]
    13. 13
  13. Strålin, K., H. Holmberg, and P. Olcén. 2004. Antibody response to the patient's own Haemophilus influenzae isolate can support the aetiology in lower respiratory tract infections. APMIS 112:299-303.[CrossRef][Medline]
    14. 14
  14. Strålin, K., M. S. Kaltoft, H. B. Konradsen, P. Olcén, and H. Holmberg. 2004. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J. Clin. Microbiol. 42:3620-3625.[Abstract/Free Full Text]
    15. 15
  15. Wheeler, J., R. Freeman, M. Steward, K. Henderson, M. J. Lee, N. H. Piggott, G. J. Eltringham, and A. Galloway. 1999. Detection of pneumolysin in sputum. J. Med. Microbiol. 48:863-866.[Abstract/Free Full Text]

Journal of Clinical Microbiology, February 2006, p. 643-645, Vol. 44, No. 2
0095-1137/06/$08.00+0     doi:10.1128/JCM.44.2.643-645.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Brugger, S. D., Hathaway, L. J., Muhlemann, K. (2009). Detection of Streptococcus pneumoniae Strain Cocolonization in the Nasopharynx. J. Clin. Microbiol. 47: 1750-1756 [Abstract] [Full Text]  
  • Smith, M. D., Sheppard, C. L., Hogan, A., Harrison, T. G., Dance, D. A. B., Derrington, P., George, R. C., on behalf of the South West Pneumococcus Study Gro, (2009). Diagnosis of Streptococcus pneumoniae Infections in Adults with Bacteremia and Community-Acquired Pneumonia: Clinical Comparison of Pneumococcal PCR and Urinary Antigen Detection. J. Clin. Microbiol. 47: 1046-1049 [Abstract] [Full Text]  
  • Stralin, K., Korsgaard, J., Olcen, P. (2006). Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J 28: 568-575 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strålin, K.
Right arrow Articles by Holmberg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strålin, K.
Right arrow Articles by Holmberg, H.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»